Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT02049333
Eligibility Criteria:
Inclusion Criteria:
* Patient has to be ≥ 18 years of age of either gender
* Nuclear sclerotic cataract graded by LOCS III to be \< 5
* Diagnosis of Plateau Iris Configuration or Syndrome
* No contraindication for cataract or ECPL operation
* Written informed consent on IRB approved Informed Consent Form
Exclusion Criteria:
* Hard cataracts, LOCS III 5 and 6
* Ciliary body cysts
* Clinically significant sequelae from trauma in which angle anatomy/physiology may have been compromised (e.g., chemical burns, significant angle recession, blunt trauma, etc.)
* Congenital anomaly of the irido-trabecular angle
* Previous intraocular surgery
* Previous laser gonioplasty to either eye
* Placement of the intraocular lens in any place other than the capsular bag
* Pupilloplasty
* Rubeosis
* Peripheral anterior synechiae (PAS) nasal angle and/or \>180 degrees of PAS
* Neovascular glaucoma; or glaucoma associated with vascular ischemic disorders
* Active corneal inflammation or edema (e.g., keratitis, keratoconjunctivitis, keratouveitis)
* Corneal opacities or disorders that would inhibit visualization of the nasal angle
* Chronic ocular inflammatory disease or presence of active ocular inflammation with risk for synechial/proliferative changes
* Inability to attend regular follow-up assessment or to give informed written consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02049333
Study Brief:
Protocol Section:
NCT02049333